Health
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 | NEJM – nejm.org
Correspondence from The New England Journal of Medicine — SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
We conducted a global, randomized, placebo-controlled, phase 123 pivotal trial in which two 30-g doses of BNT162b2 (PfizerBioNTech) were administered 21 days apart (ClinicalTrials.gov number, NCT04368728). These doses of vaccine had mainly low-grade side…
Continue Reading
-
General14 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News20 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General15 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News11 hours agoSerious traffic crash, Noosa – Sunshine Coast